Structure

Physi-Chem Properties

Molecular Weight:  482.3
Volume:  533.183
LogP:  7.191
LogD:  4.469
LogS:  -2.431
# Rotatable Bonds:  18
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.093
Synthetic Accessibility Score:  2.698
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.126
MDCK Permeability:  2.3227963538374752e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.194
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.011
Plasma Protein Binding (PPB):  100.28975677490234%
Volume Distribution (VD):  1.35
Pgp-substrate:  0.5126007795333862%

ADMET: Metabolism

CYP1A2-inhibitor:  0.626
CYP1A2-substrate:  0.177
CYP2C19-inhibitor:  0.86
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.251
CYP2C9-substrate:  0.993
CYP2D6-inhibitor:  0.973
CYP2D6-substrate:  0.719
CYP3A4-inhibitor:  0.686
CYP3A4-substrate:  0.066

ADMET: Excretion

Clearance (CL):  5.279
Half-life (T1/2):  0.933

ADMET: Toxicity

hERG Blockers:  0.326
Human Hepatotoxicity (H-HT):  0.086
Drug-inuced Liver Injury (DILI):  0.019
AMES Toxicity:  0.041
Rat Oral Acute Toxicity:  0.028
Maximum Recommended Daily Dose:  0.961
Skin Sensitization:  0.981
Carcinogencity:  0.025
Eye Corrosion:  0.036
Eye Irritation:  0.944
Respiratory Toxicity:  0.708

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC140521

Natural Product ID:  NPC140521
Common Name*:   Oncostemonol B
IUPAC Name:   [3-[(Z)-16-(3,5-dihydroxyphenyl)hexadec-8-enyl]-5-hydroxyphenyl] acetate
Synonyms:   oncostemonol B
Standard InCHIKey:  CATXXSJNZBRPTC-IHWYPQMZSA-N
Standard InCHI:  InChI=1S/C30H42O5/c1-24(31)35-30-21-26(20-29(34)23-30)17-15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-25-18-27(32)22-28(33)19-25/h2-3,18-23,32-34H,4-17H2,1H3/b3-2-
SMILES:  CC(=O)Oc1cc(CCCCCCC/C=CCCCCCCCc2cc(cc(c2)O)O)cc(c1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL458522
PubChem CID:   11755009
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002319] Phenol esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33313 oncostemon bojerianum Species n.a. n.a. leaves Madagascar rainforest n.a. PMID[12444688]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 = 10.2 ug.mL-1 PMID[452376]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC140521 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9915 High Similarity NPC249836
0.9831 High Similarity NPC78446
0.9316 High Similarity NPC471498
0.9316 High Similarity NPC471503
0.9153 High Similarity NPC470759
0.9153 High Similarity NPC127894
0.9153 High Similarity NPC15860
0.9153 High Similarity NPC219070
0.9083 High Similarity NPC473290
0.9083 High Similarity NPC471504
0.9068 High Similarity NPC114064
0.8983 High Similarity NPC53906
0.8898 High Similarity NPC276737
0.8898 High Similarity NPC22610
0.8898 High Similarity NPC32463
0.8833 High Similarity NPC474933
0.8833 High Similarity NPC69261
0.8833 High Similarity NPC33270
0.8828 High Similarity NPC142530
0.8803 High Similarity NPC255068
0.88 High Similarity NPC168259
0.8769 High Similarity NPC131950
0.876 High Similarity NPC245120
0.876 High Similarity NPC474635
0.875 High Similarity NPC123559
0.875 High Similarity NPC150624
0.875 High Similarity NPC141090
0.8712 High Similarity NPC474886
0.8712 High Similarity NPC476171
0.8699 High Similarity NPC218753
0.8692 High Similarity NPC474810
0.8689 High Similarity NPC184302
0.8667 High Similarity NPC167934
0.8667 High Similarity NPC808
0.8661 High Similarity NPC470699
0.8661 High Similarity NPC243688
0.8636 High Similarity NPC471719
0.8629 High Similarity NPC187868
0.8629 High Similarity NPC476633
0.8629 High Similarity NPC52247
0.8626 High Similarity NPC309744
0.8626 High Similarity NPC111635
0.8607 High Similarity NPC190514
0.8583 High Similarity NPC181361
0.8583 High Similarity NPC228287
0.8583 High Similarity NPC180508
0.8561 High Similarity NPC252095
0.856 High Similarity NPC18128
0.856 High Similarity NPC77789
0.8559 High Similarity NPC168657
0.8559 High Similarity NPC2682
0.8559 High Similarity NPC94045
0.8538 High Similarity NPC147317
0.8538 High Similarity NPC472590
0.8538 High Similarity NPC8899
0.8538 High Similarity NPC250727
0.8537 High Similarity NPC137294
0.8537 High Similarity NPC85895
0.8525 High Similarity NPC195466
0.8525 High Similarity NPC244816
0.8525 High Similarity NPC50521
0.8525 High Similarity NPC221549
0.8516 High Similarity NPC46978
0.8516 High Similarity NPC210355
0.8504 High Similarity NPC244495
0.8504 High Similarity NPC93219
0.8492 Intermediate Similarity NPC282496
0.8492 Intermediate Similarity NPC136319
0.8492 Intermediate Similarity NPC38761
0.8492 Intermediate Similarity NPC233526
0.8492 Intermediate Similarity NPC76465
0.8492 Intermediate Similarity NPC315807
0.8473 Intermediate Similarity NPC5423
0.8473 Intermediate Similarity NPC469611
0.8462 Intermediate Similarity NPC79184
0.8462 Intermediate Similarity NPC307042
0.845 Intermediate Similarity NPC474651
0.845 Intermediate Similarity NPC185066
0.845 Intermediate Similarity NPC219923
0.845 Intermediate Similarity NPC469453
0.845 Intermediate Similarity NPC210674
0.845 Intermediate Similarity NPC474623
0.8443 Intermediate Similarity NPC54507
0.8443 Intermediate Similarity NPC85292
0.8443 Intermediate Similarity NPC229147
0.8443 Intermediate Similarity NPC203113
0.8438 Intermediate Similarity NPC230479
0.8438 Intermediate Similarity NPC50315
0.8438 Intermediate Similarity NPC283049
0.8438 Intermediate Similarity NPC26879
0.8433 Intermediate Similarity NPC38874
0.8425 Intermediate Similarity NPC228972
0.8425 Intermediate Similarity NPC270030
0.8425 Intermediate Similarity NPC122792
0.8417 Intermediate Similarity NPC280606
0.8413 Intermediate Similarity NPC302211
0.8413 Intermediate Similarity NPC36016
0.8413 Intermediate Similarity NPC100099
0.8413 Intermediate Similarity NPC74137
0.8409 Intermediate Similarity NPC469610
0.8409 Intermediate Similarity NPC31849
0.8406 Intermediate Similarity NPC125617
0.84 Intermediate Similarity NPC302107
0.84 Intermediate Similarity NPC102639
0.8394 Intermediate Similarity NPC110067
0.8394 Intermediate Similarity NPC34245
0.8394 Intermediate Similarity NPC7439
0.8394 Intermediate Similarity NPC91492
0.8394 Intermediate Similarity NPC256555
0.839 Intermediate Similarity NPC245115
0.8385 Intermediate Similarity NPC93962
0.8385 Intermediate Similarity NPC222108
0.8385 Intermediate Similarity NPC16577
0.8385 Intermediate Similarity NPC474289
0.8385 Intermediate Similarity NPC96719
0.8376 Intermediate Similarity NPC39097
0.8376 Intermediate Similarity NPC118286
0.8376 Intermediate Similarity NPC109691
0.8376 Intermediate Similarity NPC470700
0.8376 Intermediate Similarity NPC39664
0.8376 Intermediate Similarity NPC302681
0.8372 Intermediate Similarity NPC194841
0.8372 Intermediate Similarity NPC473221
0.8372 Intermediate Similarity NPC474670
0.8372 Intermediate Similarity NPC121740
0.8372 Intermediate Similarity NPC474821
0.8372 Intermediate Similarity NPC224774
0.8372 Intermediate Similarity NPC257947
0.8372 Intermediate Similarity NPC66331
0.8372 Intermediate Similarity NPC258567
0.8361 Intermediate Similarity NPC185541
0.8361 Intermediate Similarity NPC464
0.8359 Intermediate Similarity NPC475169
0.8359 Intermediate Similarity NPC476254
0.8359 Intermediate Similarity NPC203133
0.8359 Intermediate Similarity NPC221077
0.8359 Intermediate Similarity NPC131397
0.8359 Intermediate Similarity NPC105925
0.8359 Intermediate Similarity NPC298757
0.8359 Intermediate Similarity NPC472093
0.8359 Intermediate Similarity NPC285040
0.8359 Intermediate Similarity NPC113495
0.8359 Intermediate Similarity NPC251855
0.8359 Intermediate Similarity NPC17809
0.8359 Intermediate Similarity NPC117214
0.8359 Intermediate Similarity NPC57490
0.8359 Intermediate Similarity NPC193544
0.8359 Intermediate Similarity NPC116907
0.8359 Intermediate Similarity NPC188022
0.8359 Intermediate Similarity NPC102540
0.8359 Intermediate Similarity NPC208950
0.8359 Intermediate Similarity NPC17943
0.8359 Intermediate Similarity NPC233410
0.8359 Intermediate Similarity NPC103420
0.8346 Intermediate Similarity NPC96940
0.8345 Intermediate Similarity NPC29577
0.8345 Intermediate Similarity NPC475896
0.8333 Intermediate Similarity NPC470752
0.8333 Intermediate Similarity NPC194277
0.8333 Intermediate Similarity NPC471824
0.8333 Intermediate Similarity NPC54972
0.8333 Intermediate Similarity NPC212965
0.8333 Intermediate Similarity NPC36732
0.8333 Intermediate Similarity NPC296920
0.8333 Intermediate Similarity NPC75713
0.8333 Intermediate Similarity NPC90520
0.8321 Intermediate Similarity NPC476399
0.8321 Intermediate Similarity NPC472338
0.8321 Intermediate Similarity NPC262606
0.8321 Intermediate Similarity NPC474617
0.832 Intermediate Similarity NPC247553
0.8308 Intermediate Similarity NPC38664
0.8308 Intermediate Similarity NPC474616
0.8308 Intermediate Similarity NPC474636
0.8308 Intermediate Similarity NPC274717
0.8308 Intermediate Similarity NPC53986
0.8306 Intermediate Similarity NPC131118
0.8305 Intermediate Similarity NPC54844
0.8305 Intermediate Similarity NPC35543
0.8296 Intermediate Similarity NPC105493
0.8296 Intermediate Similarity NPC131198
0.8296 Intermediate Similarity NPC124149
0.8295 Intermediate Similarity NPC82299
0.8295 Intermediate Similarity NPC276212
0.8295 Intermediate Similarity NPC101894
0.8295 Intermediate Similarity NPC474632
0.8291 Intermediate Similarity NPC134829
0.8291 Intermediate Similarity NPC246056
0.8286 Intermediate Similarity NPC170239
0.8286 Intermediate Similarity NPC237208
0.8286 Intermediate Similarity NPC275125
0.8286 Intermediate Similarity NPC97937
0.8284 Intermediate Similarity NPC311430
0.8284 Intermediate Similarity NPC224941
0.8281 Intermediate Similarity NPC159132
0.8281 Intermediate Similarity NPC73413
0.8281 Intermediate Similarity NPC246648
0.8281 Intermediate Similarity NPC134195
0.8281 Intermediate Similarity NPC197351
0.8281 Intermediate Similarity NPC86502

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC140521 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8629 High Similarity NPD422 Phase 1
0.8462 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8385 Intermediate Similarity NPD4625 Phase 3
0.8346 Intermediate Similarity NPD4749 Approved
0.8308 Intermediate Similarity NPD4908 Phase 1
0.8268 Intermediate Similarity NPD1608 Approved
0.8264 Intermediate Similarity NPD5535 Approved
0.8189 Intermediate Similarity NPD1610 Phase 2
0.8188 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8168 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD1548 Phase 1
0.8106 Intermediate Similarity NPD3027 Phase 3
0.8092 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8077 Intermediate Similarity NPD2797 Approved
0.8065 Intermediate Similarity NPD6671 Approved
0.8045 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8031 Intermediate Similarity NPD17 Approved
0.8029 Intermediate Similarity NPD6099 Approved
0.8029 Intermediate Similarity NPD6100 Approved
0.8 Intermediate Similarity NPD3225 Approved
0.797 Intermediate Similarity NPD7095 Approved
0.7929 Intermediate Similarity NPD3750 Approved
0.7926 Intermediate Similarity NPD1613 Approved
0.7926 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7926 Intermediate Similarity NPD4060 Phase 1
0.791 Intermediate Similarity NPD3268 Approved
0.7868 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7868 Intermediate Similarity NPD5124 Phase 1
0.7829 Intermediate Similarity NPD3496 Discontinued
0.777 Intermediate Similarity NPD1551 Phase 2
0.7769 Intermediate Similarity NPD1611 Approved
0.7752 Intermediate Similarity NPD1778 Approved
0.7744 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7698 Intermediate Similarity NPD7033 Discontinued
0.7687 Intermediate Similarity NPD2861 Phase 2
0.7674 Intermediate Similarity NPD5585 Approved
0.7669 Intermediate Similarity NPD1203 Approved
0.7651 Intermediate Similarity NPD7819 Suspended
0.7647 Intermediate Similarity NPD1242 Phase 1
0.7634 Intermediate Similarity NPD1535 Discovery
0.763 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7623 Intermediate Similarity NPD968 Approved
0.7589 Intermediate Similarity NPD5762 Approved
0.7589 Intermediate Similarity NPD5763 Approved
0.7586 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD4750 Phase 3
0.7576 Intermediate Similarity NPD1481 Phase 2
0.7571 Intermediate Similarity NPD4308 Phase 3
0.7571 Intermediate Similarity NPD3748 Approved
0.7557 Intermediate Similarity NPD3847 Discontinued
0.755 Intermediate Similarity NPD7768 Phase 2
0.7537 Intermediate Similarity NPD3266 Approved
0.7537 Intermediate Similarity NPD3267 Approved
0.7536 Intermediate Similarity NPD4140 Approved
0.7535 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7519 Intermediate Similarity NPD2982 Phase 2
0.7519 Intermediate Similarity NPD2983 Phase 2
0.7518 Intermediate Similarity NPD2935 Discontinued
0.7518 Intermediate Similarity NPD1296 Phase 2
0.7517 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7075 Discontinued
0.75 Intermediate Similarity NPD6832 Phase 2
0.7483 Intermediate Similarity NPD1652 Phase 2
0.7482 Intermediate Similarity NPD6355 Discontinued
0.7481 Intermediate Similarity NPD6584 Phase 3
0.7481 Intermediate Similarity NPD4626 Approved
0.7466 Intermediate Similarity NPD7447 Phase 1
0.7465 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7465 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7463 Intermediate Similarity NPD6696 Suspended
0.7462 Intermediate Similarity NPD1894 Discontinued
0.7448 Intermediate Similarity NPD6666 Approved
0.7448 Intermediate Similarity NPD6667 Approved
0.7444 Intermediate Similarity NPD9717 Approved
0.7444 Intermediate Similarity NPD2981 Phase 2
0.7438 Intermediate Similarity NPD846 Approved
0.7438 Intermediate Similarity NPD940 Approved
0.7434 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD1653 Approved
0.7431 Intermediate Similarity NPD4628 Phase 3
0.7431 Intermediate Similarity NPD3892 Phase 2
0.7429 Intermediate Similarity NPD6653 Approved
0.7426 Intermediate Similarity NPD3018 Phase 2
0.7417 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD1549 Phase 2
0.741 Intermediate Similarity NPD1240 Approved
0.7402 Intermediate Similarity NPD7843 Approved
0.74 Intermediate Similarity NPD7411 Suspended
0.7398 Intermediate Similarity NPD9697 Approved
0.7397 Intermediate Similarity NPD7837 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD6799 Approved
0.7397 Intermediate Similarity NPD1511 Approved
0.7394 Intermediate Similarity NPD6032 Approved
0.7391 Intermediate Similarity NPD6798 Discontinued
0.7388 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD4359 Approved
0.7372 Intermediate Similarity NPD2614 Approved
0.7368 Intermediate Similarity NPD1091 Approved
0.7364 Intermediate Similarity NPD7157 Approved
0.7361 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD2684 Approved
0.7357 Intermediate Similarity NPD4340 Discontinued
0.7351 Intermediate Similarity NPD1934 Approved
0.7347 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD5283 Phase 1
0.7338 Intermediate Similarity NPD6233 Phase 2
0.7338 Intermediate Similarity NPD8032 Phase 2
0.7333 Intermediate Similarity NPD1283 Approved
0.7324 Intermediate Similarity NPD1510 Phase 2
0.7311 Intermediate Similarity NPD2860 Approved
0.7311 Intermediate Similarity NPD2859 Approved
0.731 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD7229 Phase 3
0.7305 Intermediate Similarity NPD1607 Approved
0.7303 Intermediate Similarity NPD2801 Approved
0.7297 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD1512 Approved
0.7286 Intermediate Similarity NPD4307 Phase 2
0.7279 Intermediate Similarity NPD7213 Phase 3
0.7279 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD7212 Phase 2
0.7273 Intermediate Similarity NPD3749 Approved
0.7273 Intermediate Similarity NPD2796 Approved
0.7273 Intermediate Similarity NPD5691 Approved
0.7273 Intermediate Similarity NPD3020 Approved
0.7273 Intermediate Similarity NPD6971 Discontinued
0.7267 Intermediate Similarity NPD3226 Approved
0.7267 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7266 Intermediate Similarity NPD411 Approved
0.7259 Intermediate Similarity NPD6582 Phase 2
0.7259 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD6583 Phase 3
0.7255 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD5402 Approved
0.7255 Intermediate Similarity NPD3817 Phase 2
0.7248 Intermediate Similarity NPD5403 Approved
0.7244 Intermediate Similarity NPD7199 Phase 2
0.7237 Intermediate Similarity NPD37 Approved
0.7234 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD447 Suspended
0.7227 Intermediate Similarity NPD2933 Approved
0.7227 Intermediate Similarity NPD2934 Approved
0.7226 Intermediate Similarity NPD6234 Discontinued
0.7222 Intermediate Similarity NPD6005 Phase 3
0.7222 Intermediate Similarity NPD6004 Phase 3
0.7222 Intermediate Similarity NPD7266 Discontinued
0.7222 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6002 Phase 3
0.7219 Intermediate Similarity NPD6599 Discontinued
0.7218 Intermediate Similarity NPD2423 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD4062 Phase 3
0.7208 Intermediate Similarity NPD4967 Phase 2
0.7208 Intermediate Similarity NPD3882 Suspended
0.7208 Intermediate Similarity NPD4965 Approved
0.7208 Intermediate Similarity NPD4966 Approved
0.7203 Intermediate Similarity NPD2799 Discontinued
0.72 Intermediate Similarity NPD3134 Approved
0.7194 Intermediate Similarity NPD5163 Phase 2
0.719 Intermediate Similarity NPD1465 Phase 2
0.7188 Intermediate Similarity NPD5844 Phase 1
0.7188 Intermediate Similarity NPD228 Approved
0.7185 Intermediate Similarity NPD2231 Phase 2
0.7185 Intermediate Similarity NPD2235 Phase 2
0.7179 Intermediate Similarity NPD6746 Phase 2
0.7165 Intermediate Similarity NPD3021 Approved
0.7165 Intermediate Similarity NPD3022 Approved
0.7163 Intermediate Similarity NPD1558 Phase 1
0.7153 Intermediate Similarity NPD6362 Approved
0.7152 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1358 Approved
0.7143 Intermediate Similarity NPD290 Approved
0.7143 Intermediate Similarity NPD2313 Discontinued
0.7143 Intermediate Similarity NPD3764 Approved
0.7133 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD7097 Phase 1
0.7133 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD6801 Discontinued
0.7123 Intermediate Similarity NPD1243 Approved
0.7123 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7644 Approved
0.7114 Intermediate Similarity NPD5401 Approved
0.7114 Intermediate Similarity NPD2533 Approved
0.7114 Intermediate Similarity NPD2532 Approved
0.7114 Intermediate Similarity NPD2534 Approved
0.7113 Intermediate Similarity NPD230 Phase 1
0.7111 Intermediate Similarity NPD1281 Approved
0.7107 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD2346 Discontinued
0.7099 Intermediate Similarity NPD709 Approved
0.7092 Intermediate Similarity NPD4870 Approved
0.709 Intermediate Similarity NPD2107 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD6232 Discontinued
0.7086 Intermediate Similarity NPD2370 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD8651 Approved
0.7075 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD4110 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data